Table 1.
Model System | Protein | Change | Reference |
---|---|---|---|
Mouse embryonic fibroblast (MEF) cultures in adipogenic differentiation medium; WT vs. Fst KO |
UCP1 | ↓ | (144) |
PRDM16 | ↓ | (144) | |
aP2 | ↓ | (144) | |
PPARγ | ↓ | (144) | |
PGC-1α | ↓ | (144) | |
Cyt C | ↓ | (144) | |
Interscapular brown adipose tissue (BAT); WT vs. Fst-Tg | UCP1 | ↑ | (147) |
UCP2 | ↑ | (147) | |
UCP3 | ↑ | (147) | |
PRDM16 | ↑ | (147) | |
PGC-1α | ↑ | (147) | |
AdipoQ | ↑ | (147) | |
Myf5 | ↑ | (147) | |
pSmad3 | ↓ | (147) | |
Smad3 | ↓ | (147) | |
ActRIIB | ↓ | (147) | |
Epididymal and subcutaneous adipose tissue; WT vs. Fst-Tg | UCP1 | ↑ | (147) |
UCP2 | ↑ | (147) | |
UCP3 | ↑ | (147) | |
PRDM16 | ↑ | (147) | |
PGC1α | ↑ | (147) | |
BMP7 | ↑ | (147) | |
Glut4 | ↑ | (147) | |
CD137 | ↑ | (147) | |
pp38 MAPK | ↑ | (147) | |
pERK1/2 | ↑ | (147) | |
pSmad3 | ↓ | (147) | |
Smad3 | ↓ | (147) | |
ActRIIB | ↓ | (147) | |
AdipoQ | ↑ | (148) | |
FGF21 | ↑ | (148) | |
pAMPK | ↑ | (148) | |
Differentiating 3T3-L1 cells treated with recombinant FST (rFST); Control vs. rFST | UCP1 | ↑ | (147) |
CD137 | ↑ | (147) | |
pp38 MAPK | ↑ | (147) | |
pERK1/2 | ↑ | (147) | |
AdipoQ | ↑ | (148) | |
AdipoR1 | ↑ | (148) | |
FGF21 | ↑ | (148) | |
pAMPK | ↑ | (148) | |
PGC-1α | ↑ | (148) | |
SirT1 | ↑ | (148) | |
Mouse brown adipose tissue (BAT) cells treated with rFST: Con vs. rFST | UCP1 | ↑ | (147) |
Eva1 | ↑ | (147) | |
Myf5 | ↑ | (147) | |
Fst overexpressing stable 3T3-L1 (3T3-L1 Fst) cells; 3T3-L1-Fst vs. 3T3-L1 | UCP1 | ↑ | (148) |
CD137 | ↑ | (148) | |
p38 MAPK | ↑ | (148) | |
pERK1/2 | ↑ | (148) | |
COX-IV | ↑ | (148) | |
SirT1 | ↑ | (148) | |
SirT3 | ↑ | (148) | |
AdipoQ | ↑ | (148) |